Bharat Immunologicals (India) Management Performance Evaluation

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

Analysis of Bharat Immunologicals manpower and management performance can provide insight into Bharat Immunologicals stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Bharat Immunologicals future performance. Check also Trending Equities.
Symbol  BIBCL
Name  Bharat Immunologicals Biologicals Corp Ltd
TypeStock
Country   India
Exchange  Bombay

Information on Bharat Immunologicals Biologicals Corp Ltd Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out.

Currently Trending

APHQF   
Purchased over 300 shares of
3 days ago
Traded for 9.556
LOB   
Purchased over 100 shares of
3 days ago
Traded for 29.25
ETFC   
Purchased over 40 shares of
3 days ago
Traded for 64.51
FFWC   
Purchased over 60 shares of
3 days ago
Traded for 43.0
RYFL   
Purchased over 100 shares of
3 days ago
Traded for 16.15

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Bharat Immunologicals Management Effectiveness

The company has return on total asset (ROA) of (1.69) % which means that it has lost $1.69 on every $100 spent on asset. This is way below average.

Bharat Immunologicals Profit Margins

The company has Profit Margin (PM) of 0.38 % which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 4.32 % which suggests for every 100 dollars of sales it generated a net operating income of 0.04.

Bharat Immunologicals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of seventeen. Bharat Immunologicals Price Series Summation is a cross summation of Bharat Immunologicals price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bharat Immunologicals Biologicals Corp Ltd to your portfolio
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.